Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017430
Filing Date
2017-08-11
Accepted
2017-08-11 16:53:48
Documents
91
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20170630.htm 10-Q 1906059
2 EX-10.1 reph-ex101_328.htm EX-10.1 41379
3 EX-10.2 reph-ex102_329.htm EX-10.2 627548
4 EX-10.3 reph-ex103_327.htm EX-10.3 640140
5 EX-10.4 reph-ex104_326.htm EX-10.4 136728
6 EX-31.1 reph-ex311_7.htm EX-31.1 17721
7 EX-31.2 reph-ex312_8.htm EX-31.2 17279
8 EX-31.3 reph-ex313_49.htm EX-31.3 17277
9 EX-32.1 reph-ex321_6.htm EX-32.1 9544
  Complete submission text file 0001564590-17-017430.txt   10066790

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT reph-20170630.xml EX-101.INS 2082538
11 XBRL TAXONOMY EXTENSION SCHEMA reph-20170630.xsd EX-101.SCH 62145
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20170630_cal.xml EX-101.CAL 61001
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20170630_def.xml EX-101.DEF 220119
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20170630_lab.xml EX-101.LAB 478971
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20170630_pre.xml EX-101.PRE 396295
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 171025789
SIC: 2834 Pharmaceutical Preparations